Table 1

Currently available COVID-19 vaccine trial data for selected trials

Trial ID; no enrolled; included ages	Pre-study documents	Post-study documents†					Total pages available§
Trial ID; no enrolled; included ages	Pre-study documents	Press release	Pub	CSR	Other‡	IPD	Total pages available§
Pfizer BNT162b2 mRNA vaccine
NCT04368728 ; n=43 998; 12–85 years	Protocol , SAP , Blank CRF	Press release 1 , 2 , 3	Pub 1 , 2 , 3	CSR	Other	No	3880
NCT04713553 ; n=1530; 12–50 years	None	No	N/A: trial ongoing				0
NCT04816643 ; n=4644; 6 months to 11 years	None	No	N/A: trial ongoing				0
Moderna mRNA-127 vaccine
NCT04470427 ; n=30 420; ≥18 years	Protocol , SAP	Press release	Pub	No	Other	No	3293
NCT04811664 ; n=37 500; 18–26 years	None	No	N/A: trial ongoing				0
NCT04796896 ; n=6750; 6 months to 12 years	None	No	N/A: trial ongoing				0
Oxford/AstraZeneca ChAdOx1 vaccine
ISRCTN89951424 ; n=10 300; ≥18 years	Protocol	Press release	Pub 1¶, 2¶	No	No	No	123
NCT04400838 ; n=12 390; ≥18 years	Protocol	Press release	Pub 1¶, 2¶	No	No	No	214
ISRCTN15638344 ; n=300; 6–17 years	None	No	N/A: trial ongoing				0
Janssen (Johnson & Johnson) Ad26.COV2.S vaccine
NCT04505722 ; n=44 325; ≥18 years	Protocol , SAP , Blank ICF	Press release	Pub	No	No	No	530
NCT04535453 ; n=1210; 12 to 55, ≥65 years	None	No	N/A: trial ongoing				0
NCT04614948 ; n=30 000; ≥18 years	Protocol	No	N/A: trial ongoing				166
Novavax SARS-CoV-2 rS/Matrix-M1 Adjuvanted vaccine
NCT04611802 ; n=30 000; ≥18 years	Protocol	No	N/A: trial ongoing				128
NCT04368988 ; n=1419; 18–84 years	Protocol , SAP	Press release	N/A: trial ongoing				189
NCT04583995 ; n=15 187; 18–84 years	Protocol , SAP	Press release	Pub	No	No	No	128
Gamaleya Research Institute Sputnik V/Gam-COVID-Vac vaccine
NCT04530396 ; n=33 758; ≥18 years	None	Press release	Pub	No	No	No	11
NCT04741061 ; n=6000; ≥18 years	None	No	N/A: trial ongoing				0
NCT04642339 ; n=2000; ≥18 years	None	No	N/A: trial ongoing				0
Sinopharm (BIBP) vaccine
ChiCTR2000032459 ; n=2128; ≥3 years	None	No	Pub	No	No	No	13
NCT04510207; n=45 000; ≥18 years	Protocol , SAP	No	Pub	No	No	No	102
NCT04612972 ; n=12 000; ≥18 years	None	No	N/A: trial ongoing				0
Sinovac (CoronaVac) vaccine
NCT04456595 ; n=12 688; ≥18 years	Protocol	Press release	Pub	No	No	No	201
NCT04551547 ; n=552; 3–17 years	None	No	Pub	No	No	No	22
NCT04582344 ; n=13 000; 18–59 years	Protocol	Press release	No	No	No	No	57

Data current as of 27 June 2021.
*Pre-study documents include: protocol, statistical analysis plan, blank informed consent form, blank case report form, data monitoring board charter, event adjudication committee charter, investigational medicinal product dossier and investigator’s brochure.
†Post-study documents include: press releases (that contain any results), journal publication (including pre-prints), clinical study report and individual participant data.
‡Other includes documents released by Health Canada and EMA other than the CSR.
§Total pages available excludes press releases. Access to the dataset used to determine page count for trials where additional data were available through Health Canada and the European Medicines Agency is available in the Zenodo repository (http://doi.org/10.5281/zenodo.4737417).
¶Pooled trial analysis publication listed if there were no individual trial publications.
CRF, case report form; CSR, clinical study report; EMA, European Medicines Agency; ICF, informed consent form; IPD, individual participant data; n, number enrolled in trial; N/A, not applicable; Pub, journal publication ; SAP, statistical analysis plan.